Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02891070 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery
A Phase 3 study, sponsored by Baxter Healthcare Corporation.
- Completed
- Registry status
- Phase 3
- Development phase
- 224
- Enrollment target
NCT02891070 is a Phase 3 study that has completed, run by Baxter Healthcare Corporation. The registered enrollment target is 224 participants.
The verdict
NCT02891070, a Phase 3 study, has completed, sponsored by Baxter Healthcare Corporation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 224 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the safety and efficacy of FS VH S/D 500 s-apr for use as an adjunct to sutured dural repair in cranial surgery.
Interventions
- DRUG FS VH S/D 500 s-apr
- DEVICE DuraSeal Dural Sealant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2016-10-11 |
| Est. Completion | 2018-08-22 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02891070
The ClinicalTrials.gov registry entry for NCT02891070 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baxter Healthcare Corporation, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which FS VH S/D 500 s-apr is the first listed.
NCT02891070 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02891070 about?
NCT02891070 is a clinical study titled "Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery". The objective of this study is to evaluate the safety and efficacy of FS VH S/D 500 s-apr for use as an adjunct to sutured dural repair in cranial surgery.
What is the current status of trial NCT02891070?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 224 participants. The study started on 2016-10-11. Estimated completion is 2018-08-22.
What interventions are being tested in trial NCT02891070?
The interventions under investigation include: FS VH S/D 500 s-apr (DRUG), DuraSeal Dural Sealant (DEVICE).
Who is sponsoring clinical trial NCT02891070?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.